Compound Evidence File
#EC-2026-0155
Primobolan Oral (Methenolone Acetate)
Filed under Oral Tablets. The bureau holds 159 laboratory returns for this compound from 62 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
62 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 8 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| HomopeptideCASE #VI-2026-0760 | A | 7 | 10.0 | 9.9 | 10.0 | 21 May 2026 | 21 May 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 4 | 10.0 | 10.0 | 10.0 | 23 Apr 2026 | 20 Jun 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 3 | 10.0 | 10.0 | 10.0 | 13 Apr 2026 | 3 Jul 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 3 | 10.0 | 9.9 | 10.0 | 3 Apr 2026 | 3 Jun 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 3 | 10.0 | 9.9 | 10.0 | 9 Apr 2026 | 17 May 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 2 | 10.0 | 10.0 | 10.0 | 10 Nov 2025 | 3 May 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 2 | 10.0 | 10.0 | 10.0 | 11 Jul 2026 | 4 Aug 2026 |
| AsymchemCASE #VI-2026-0091 | A | 2 | 10.0 | 10.0 | 10.0 | 1 Jul 2026 | 10 Jul 2026 |
| Yabang PeptideCASE #VI-2026-0148 | X | 1 | 10.0 | 10.0 | 10.0 | 13 Jun 2025 | 13 Jun 2025 |
| Sangon BioCASE #VI-2026-0671 | A | 4 | 9.9 | 9.9 | 10.0 | 14 Jan 2026 | 12 Jun 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 4 | 9.9 | 9.9 | 10.0 | 17 Apr 2026 | 9 Jul 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 4 | 9.9 | 9.9 | 10.0 | 17 Jan 2026 | 1 Jul 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 4 | 9.9 | 9.9 | 10.0 | 12 Feb 2026 | 6 Jul 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 4 | 9.9 | 9.9 | 10.0 | 5 Nov 2025 | 13 Jun 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 4 | 9.9 | 9.9 | 10.0 | 28 Jan 2026 | 22 Jun 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 4 | 9.9 | 9.9 | 10.0 | 19 Feb 2026 | 15 Aug 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 3 | 9.9 | 9.9 | 10.0 | 8 Mar 2026 | 20 Jul 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 2 | 9.9 | 9.9 | 10.0 | 26 Feb 2026 | 5 May 2026 |
| BachemCASE #VI-2026-0314 | A | 2 | 9.9 | 9.9 | 10.0 | 27 Mar 2026 | 16 May 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 2 | 9.9 | 9.9 | 10.0 | 10 Apr 2026 | 22 May 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 2 | 9.9 | 9.9 | 10.0 | 5 Dec 2025 | 2 Feb 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 2 | 9.9 | 9.9 | 10.0 | 28 May 2026 | 9 Jul 2026 |
| SinoPepCASE #VI-2026-0387 | A | 2 | 9.9 | 9.9 | 10.0 | 9 May 2026 | 16 Aug 2026 |
| ScienceCASE #VI-2026-0636 | X | 1 | 9.6 | 9.6 | 9.6 | 2 Jul 2025 | 2 Jul 2025 |
| Peptide CraftersCASE #VI-2026-0994 | X | 1 | 9.5 | 9.5 | 9.5 | 17 Dec 2024 | 17 Dec 2024 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 7 | 9.3 | 8.7 | 10.0 | 21 May 2026 | 21 May 2026 |
| Shanghai JinBei Chemical TechnologyCASE #VI-2026-0107 | X | 1 | 9.1 | 9.1 | 9.1 | 2 Jul 2025 | 2 Jul 2025 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 5 | 8.9 | 7.6 | 9.9 | 23 May 2026 | 23 May 2026 |
| Anlv BiotechnologyCASE #VI-2026-0110 | X | 1 | 8.7 | 8.7 | 8.7 | 2 Apr 2025 | 2 Apr 2025 |
| Risynth BioCASE #VI-2026-0672 | X | 1 | 8.6 | 8.6 | 8.6 | 16 Mar 2025 | 16 Mar 2025 |
| TCICASE #VI-2026-0650 | X | 1 | 8.4 | 8.4 | 8.4 | 27 Feb 2025 | 27 Feb 2025 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 6 | 8.2 | 6.6 | 9.9 | 24 May 2026 | 24 May 2026 |
| UtherCASE #VI-2026-0902 | X | 3 | 8.2 | 7.6 | 9.2 | 20 Jun 2025 | 20 May 2026 |
| Hebei Rimao TechnologyCASE #VI-2026-0529 | X | 2 | 8.0 | 6.6 | 9.4 | 14 Jan 2025 | 21 May 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 2 | 7.8 | 7.5 | 8.1 | 23 May 2026 | 23 May 2026 |
| Modern AminosCASE #VI-2026-0635 | X | 1 | 7.8 | 7.8 | 7.8 | 8 Jul 2025 | 8 Jul 2025 |
| Lisa BiopeptideCASE #VI-2026-0131 | X | 1 | 7.7 | 7.7 | 7.7 | 20 Jun 2025 | 20 Jun 2025 |
| Peptide PartnersCASE #VI-2026-0295 | X | 5 | 7.5 | 6.7 | 8.1 | 11 Jun 2025 | 17 May 2026 |
| Skye PeptidesCASE #VI-2026-0451 | X | 4 | 7.5 | 6.5 | 9.5 | 2 Apr 2025 | 24 May 2026 |
| Bulk Peptide SupplyCASE #VI-2026-0446 | X | 1 | 7.5 | 7.5 | 7.5 | 25 Apr 2025 | 25 Apr 2025 |
| Peptide WorldwideCASE #VI-2026-0217 | X | 1 | 7.5 | 7.5 | 7.5 | 28 Mar 2025 | 28 Mar 2025 |
| Prime PeptidesCASE #VI-2026-0696 | X | 1 | 7.4 | 7.4 | 7.4 | 9 Jun 2025 | 9 Jun 2025 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 2 | 7.2 | 7.2 | 7.3 | 21 May 2026 | 21 May 2026 |
| Xian Yihang TechnologyCASE #VI-2026-0656 | X | 2 | 7.1 | 5.3 | 8.8 | 16 Mar 2025 | 23 May 2026 |
| Verified PeptidesCASE #VI-2026-0407 | X | 2 | 7.0 | 6.1 | 8.0 | 13 Jun 2025 | 17 May 2026 |
| HK PeptidesCASE #VI-2026-0140 | X | 6 | 6.7 | 5.3 | 8.0 | 13 Jun 2025 | 24 May 2026 |
| Mai PeptideCASE #VI-2026-0769 | X | 4 | 6.7 | 5.1 | 8.5 | 8 Jul 2025 | 23 May 2026 |
| The Naughty NeedleCASE #VI-2026-0432 | X | 1 | 6.6 | 6.6 | 6.6 | 28 Mar 2025 | 28 Mar 2025 |
| Bio PepzCASE #VI-2026-0436 | X | 1 | 6.5 | 6.5 | 6.5 | 16 Mar 2025 | 16 Mar 2025 |
| Evolve BioPepCASE #VI-2026-0755 | X | 1 | 6.4 | 6.4 | 6.4 | 7 May 2025 | 7 May 2025 |
| Xingtai Pukelai Technology CoCASE #VI-2026-0850 | X | 1 | 6.3 | 6.3 | 6.3 | 11 Jun 2025 | 11 Jun 2025 |
| ZZQ PeptidesCASE #VI-2026-0550 | E | 2 | 6.1 | 6.0 | 6.2 | 14 Jan 2025 | 24 May 2026 |
| HXNetCASE #VI-2026-0061 | X | 6 | 6.1 | 3.2 | 7.6 | 2 Apr 2025 | 23 May 2026 |
| Welon Peptide SolutionsCASE #VI-2026-0478 | X | 1 | 5.4 | 5.4 | 5.4 | 13 Jun 2025 | 13 Jun 2025 |
| Guangzhou Lengiuanhuang CosmeticsCASE #VI-2026-0228 | X | 1 | 4.4 | 4.4 | 4.4 | 27 Feb 2025 | 27 Feb 2025 |
| Swiss ChemsCASE #VI-2026-0030 | X | 1 | 4.2 | 4.2 | 4.2 | 11 Jun 2025 | 11 Jun 2025 |
| Peptides For SaleCASE #VI-2026-0614 | X | 1 | 4.0 | 4.0 | 4.0 | 25 Apr 2025 | 25 Apr 2025 |
| Champion PeptideCASE #VI-2026-0909 | X | 1 | 3.9 | 3.9 | 3.9 | 3 Jun 2025 | 3 Jun 2025 |
| DeuschemCASE #VI-2026-0004 | X | 1 | 3.4 | 3.4 | 3.4 | 3 Jul 2025 | 3 Jul 2025 |
| Guangzhou Yuao TradingCASE #VI-2026-0787 | X | 1 | 0.0 | 0.0 | 0.0 | 2 Apr 2025 | 2 Apr 2025 |
| LOOKBiotechCASE #VI-2026-0807 | X | 1 | 0.0 | 0.0 | 0.0 | 17 Dec 2024 | 17 Dec 2024 |
Open any subject to view the batch-level evidence for Primobolan Oral (Methenolone Acetate) alone.